MINNEAPOLIS/ST. PAUL (08/24/2023) — Researchers from the University of Minnesota Medical School and College of Pharmacy have found that high costs for hepatic encephalopathy treatment in patients with end-stage liver disease were associated with decreased treatment retention for patients. The study results were recently published in Hepatology Communications. Hepatic encephalopathy…Read More
High Drug Cost Linked to Lower Chronic Liver Treatment Retention
